
|Articles|September 27, 2012
Supplements and Featured Publications
- Expenditures for Medicaid Patients Treated With Exenatide Compared With Other Diabetes Management Re
- Volume 18
- Issue 8 Suppl
Appendix: Expenditures for Medicaid Patients Treated With Exenatide Compared With Other Diabetes Management Regimens
Advertisement
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Enfortumab Vedotin Plus Pembro Cuts Risk of Disease Progression, Death 60% for Patients With MIBC Who Can’t Have Chemo With Bladder Removal
2
Abemaciclib Plus Endocrine Therapy Improves Overall Survival in High-Risk Early Breast Cancer
3
New Biomarkers, Drug Targets Identified for Colorectal Cancer
4
First-Line Zongertinib Yields Strong Responses in Patients With Advanced HER2-Mutant NSCLC
5